Project Details
| Status | Active |
|---|---|
| Effective start/end date | 11/1/15 → 8/31/50 |
Funding
- Onyx Pharmaceuticals, Inc.
- Amgen, Inc.
Onyx CFZ008: Phase 1b/2 Study of Carfilzomib in Combination with Dexamethasone, Mitoxantrone, PEG-asparaginase, and Vincristine (UK R3 Induction Backbone) in Children with Relapsed or Refractory Acute Lymphoblastic Leukemia
- Hijiya, Nobuko (PD/PI)
Project: Research project